VIE/ROVI (VIE/ROVI)

Vienna Stock Exchange: VIE/ROVI · EUR

€61.9

+0.10 (+0.2%)· Recorded snapshot

Market cap	3.1B
Revenue (ttm)	773.1M
Net income (ttm)	185.2M
EPS (ttm)	€3.62
P/E (trailing)	17.1x
P/E (forward)	20.6x
Dividend	€0.78 (1.26%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 773.1M
Net income (ttm): 185.2M
EPS (ttm): €3.62
P/E (trailing): 17.1x
P/E (forward): 20.6x
Market cap: 3.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E20.6

P25 14.3P50 18.7P75 25.4

Trailing P/E17.1

P25 20.4P50 26.7P75 39.7

ROE28.6

P25 4.8P50 10.6P75 20.1

ROIC16.9

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/ROVI indicators

Market & fundamental data

Available fields

229

Groups with data

Currency

EUR

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Spain
Country code	AT
Earnings date	2026-11-05
Employees	2,470
Employees change	51
Employees growth	2.56%
Enterprise value	EUR 3.1B
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1946
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	ES0157261019
Last earnings date	2026-07-23
Last refreshed	2026-10-29
Market cap	EUR 3.1B
Next earnings date	2026-11-05
Price	EUR 61.85
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	vie/ROVI
Website	https://www.rovi.es

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	30.31x
Average P/E ratio (3Y)	22.88x
Average P/E ratio (5Y)	20.66x
Earnings yield	5.85%
EV/Earnings	16.91x
EV/EBIT	20.73x
EV/EBITDA	17.14x
EV/FCF	17.45x
EV/Sales	4.05x
FCF / EV yield	5.73%
FCF yield	5.72%
Forward P/E	20.63x
Graham number	34.10039
Graham upside	-44.87%
Lynch fair value	EUR 64.14
Lynch upside	3.7%
P/B ratio	4.37x
P/E ratio	17.08x
P/FCF ratio	17.48x
P/OCF ratio	12.38x
P/S ratio	4.06x
Price / tangible book value	4.71x
Price/EBITDA ratio	17.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.51%
EBITDA margin	22.76%
Effective tax rate	21.33%
FCF margin	23.21%
Gross margin	64.73%
Operating margin	19.51%
Pretax margin	30.43%
Profit margin	23.95%
Profit per employee	EUR 74,972
Profitable quarters	62
Profitable years	22
Revenue per employee	EUR 312,977
ROA	9.44%
ROA (5Y)	15.81%
ROCE	17.74%
ROE	28.65%
ROE (5Y)	31.03%
ROIC	16.95%
ROIC (5Y)	30.52%
Tax / revenue	6.49%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	39.93%
EPS growth (Q)	246.69%
EPS growth 10Y	22.11%
EPS growth 3Y	1.32%
EPS growth 5Y	19.45%
EPS growth quarters	1
EPS growth years	1
FCF growth	138.23%
FCF growth (QoQ)	997.29%
FCF growth 3Y	42.67%
FCF growth 5Y	11.11%
Gross profit growth	7.06%
Gross profit growth (Q)	25.02%
Gross profit growth 3Y	-0.21%
Gross profit growth 5Y	12.38%
Net income growth	40%
Net income growth (Q)	246.65%
Net income growth (QoQ)	691.19%
Net income growth 3Y	-0.09%
Net income growth 5Y	17.56%
Net income growth quarters	1
Net income growth years	1
OCF growth	85.51%
OCF growth (Q)	785.65%
OCF growth (QoQ)	527.39%
OCF growth 10Y	20.79%
OCF growth 3Y	28.03%
OCF growth 5Y	11.16%
Operating income growth	-12.64%
Operating income growth (Q)	-34.06%
Operating income growth 3Y	-13.78%
Operating income growth 5Y	7.75%
Revenue growth	3.21%
Revenue growth (Q)	20.02%
Revenue growth (QoQ)	25.69%
Revenue growth 10Y	11.79%
Revenue growth 3Y	-1.87%
Revenue growth 5Y	8.3%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -73.9M
Depreciation and amortization	EUR 25.1M
EBIT	EUR 150.8M
EBITDA	EUR 176M
EPS	EUR 3.62
Financing cash flow	EUR -72.4M
Free cash flow	EUR 179.4M
Gross profit	EUR 500.4M
Income taxes	EUR 50.2M
Investing cash flow	EUR -100.2M
Net borrowing	EUR -27.6M
Net cash flow	EUR 80.9M
Net income	EUR 185.2M
Operating income	EUR 150.8M
Revenue	EUR 773.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	7.06
Book value per share	EUR 13.70
Debt / EBITDA	0.59
Debt / equity	0.15
Debt / FCF	0.6
Goodwill	EUR 2.7M
Interest coverage	37.8
Long-term assets	EUR 559.1M
Long-term liabilities	EUR 133.4M
Net cash (debt)	EUR 20.4M
Net cash / market cap	0.65%
Net debt / EBITDA	-0.12
Net debt / equity	-0.03
Net debt / FCF	-0.11
Piotroski F-Score	6
Property, plant and equipment	EUR 485.6M
Shareholders' equity	EUR 717.1M
Tangible book value	EUR 664.9M
Tangible book value per share	EUR 13.00
Total assets	EUR 1.1B
Total cash	EUR 128.1M
Total debt	EUR 107.7M
Total liabilities	EUR 410M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.77
Current assets	EUR 568M
Current liabilities	EUR 276.5M
Current ratio	2.05
Inventory turnover	0.91
Net working capital	EUR 190.5M
Quick ratio	1.04
Working capital	EUR 291.4M
Working capital turnover	2.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.05%
Dividend growth	2.6%
Dividend growth (3Y)	-9.49%
Dividend growth years	0
Dividend payment date	2026-07-15
Dividend payment years	5
Dividend payout frequency	Annual
Dividend per share	EUR 0.78
Dividend yield	1.26%
Ex-dividend date	2026-07-13
Last dividend	EUR 0.78
Payout ratio	25.83%
Shareholder yield	1.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 62.63
1D price change	0.16%
1M price change	3.78%
1M total return	3.78%
1W price change	6.64%
1W total return	6.64%
1Y price change	-3.51%
1Y return CAGR	-2.15%
1Y total return	-2.15%
20-day SMA	EUR 58.74
200-day SMA	EUR 66.28
3M price change	4.04%
3M total return	4.04%
3Y price change	19.75%
3Y return CAGR	7.54%
3Y total return	24.39%
50-day SMA	EUR 59.06
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 86.60
52-week high date	2026-04-21
52-week low	EUR 53.15
52-week low date	2026-07-15
6M price change	-24.25%
6M total return	-23.18%
All-time high	EUR 90.75
All-time high date	2024-06-06
All-time low	EUR 35.64
All-time low date	2022-12-28
Average true range (ATR)	EUR 0.87
Average volume	0
Change from 52-week high	-28.58%
Change from 52-week low	16.37%
Change from all-time high	-31.85%
Change from all-time low	73.54%
Change from open	0.08%
Day's gap	0.08%
High price	EUR 61.85
Low price	EUR 61.40
Monthly RSI	49.88
Open price	EUR 61.80
Position in 52-week range	100%
Previous close	EUR 61.75
Price vs 150-day SMA	-1.25%
Price vs 20-day SMA	5.3%
Price vs 200-day SMA	-6.69%
Price vs 50-day SMA	4.73%
Relative volume	2.22
RSI	66.8
Sharpe ratio	-0.02
Sharpe ratio (3Y)	0.34
Sortino ratio	0.14
Sortino ratio (3Y)	0.61
Weekly RSI	52.31
YTD price change	-2.29%
YTD total return	-0.91%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16.2M
Shares change (YoY)	0.05%
Shares held by institutions	14.33%

Deeper analysis on VIE/ROVI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/ROVI report

Is a complete VIE/ROVI research report available?

No complete published report is available for vie/ROVI (VIE/ROVI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/ROVI (VIE/ROVI)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/ROVI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/ROVI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/ROVI

Frequently asked questions